31st May 2012 07:00
Sinclair IS Pharma plc
Directorate Change
31 May 2012, Sinclair IS Pharma plc (AIM:SPH.L) ("Sinclair IS" or the "Company"), the international specialty pharma company, announces the resignation of Tim Wright from his position as a non-executive director.
Tim was previously CEO of Maelor plc and led its transformation into a focussed and profitable business which became IS Pharma plc. Having grown that business he was instrumental in the merger with Sinclair Pharma plc. His knowledge of the IS Pharma business and subsequent commitment to a successful integration has been invaluable and is much appreciated. He leaves Sinclair IS with the gratitude and friendship of both our Board and staff, and with our very best wishes for the success of his new company, Solent Pharma Ltd.
Ends
For further information please contact:
Sinclair IS Pharma plc | Tel: +44 (0) 20 7467 6920 |
Chris Spooner | |
Alan Olby | |
Robert Taylor | |
Jefferies Hoare Govett (NOMAD and Broker) | Tel: +44 (0) 20 7029 8000 |
Nick Adams | |
Thomas Rider | |
FTI Consulting | Tel: +44 (0) 20 7831 3113 |
Ben Atwell | |
Stephanie Cuthbert |
Notes to Editors:
About Sinclair IS Pharma plc - www.sinclairispharma.com
Sinclair IS Pharma is an international specialty pharmaceutical company focused on treatments in dermatology, wound care, oncology support and critical care through advanced surface technology and innovative delivery systems. The Company has a growing sales and marketing operation with a direct sales presence in the top five European markets and an extensive marketing partner network across selected developed and emerging markets.
Related Shares:
Sinclair Pharma